BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 24088790)

  • 1. Comparison of diagnostic efficiency between IOTA LR2 model and doctors
    Zhao B; Fu Y; Wen L; Wang Z; Fu C; Liu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1082-1088. PubMed ID: 36097776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence in malignant peripheral nerve sheath tumours: multicentre cohort study.
    Jansma CYMN; Acem I; Grünhagen DJ; Verhoef C; Martin E;
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38620136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses: A meta-analysis.
    Zhang X; Meng X; Dou T; Sun H
    Exp Ther Med; 2020 Dec; 20(6):265. PubMed ID: 33199990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to comment of Prof. Artur Czekierdowski.
    Jakiel G
    Prz Menopauzalny; 2017 Mar; 16(1):29-30. PubMed ID: 28555675
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies.
    Kaijser J
    Facts Views Vis Obgyn; 2015; 7(1):42-59. PubMed ID: 25897371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
    Van Calster B; Van Hoorde K; Valentin L; Testa AC; Fischerova D; Van Holsbeke C; Savelli L; Franchi D; Epstein E; Kaijser J; Van Belle V; Czekierdowski A; Guerriero S; Fruscio R; Lanzani C; Scala F; Bourne T; Timmerman D;
    BMJ; 2014 Oct; 349():g5920. PubMed ID: 25320247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.
    Testa A; Kaijser J; Wynants L; Fischerova D; Van Holsbeke C; Franchi D; Savelli L; Epstein E; Czekierdowski A; Guerriero S; Fruscio R; Leone FP; Vergote I; Bourne T; Valentin L; Van Calster B; Timmerman D
    Br J Cancer; 2014 Aug; 111(4):680-8. PubMed ID: 24937676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.
    Kaijser J; Bourne T; Valentin L; Sayasneh A; Van Holsbeke C; Vergote I; Testa AC; Franchi D; Van Calster B; Timmerman D
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):9-20. PubMed ID: 23065859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.
    Meys EM; Kaijser J; Kruitwagen RF; Slangen BF; Van Calster B; Aertgeerts B; Verbakel JY; Timmerman D; Van Gorp T
    Eur J Cancer; 2016 May; 58():17-29. PubMed ID: 26922169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancer.
    Nunes N; Ambler G; Hoo WL; Naftalin J; Foo X; Widschwendter M; Jurkovic D
    Int J Gynecol Cancer; 2013 Nov; 23(9):1583-9. PubMed ID: 24088790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
    Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancer.
    Nunes N; Yazbek J; Ambler G; Hoo W; Naftalin J; Jurkovic D
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):355-9. PubMed ID: 22223587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.
    Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.